| Dr Shelly Rhodes Weisenfeld, MD | |
|
774 Shades Mountain Plz, Hoover, AL 35226-1513 | |
| (205) 979-3381 | |
| Not Available |
| Full Name | Dr Shelly Rhodes Weisenfeld |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 28 Years |
| Location | 774 Shades Mountain Plz, Hoover, Alabama |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063444644 | NPI | - | NPPES |
| 515-96752 | Other | AL | BCBS |
| 106246 | Medicaid | AL | |
| 1063444644 | Other | AL | TRICARE SOUTH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 21225 (Alabama) | Secondary |
| 207Q00000X | Family Medicine | 21225 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tanner Medical Center-east Alabama | Wedowee, AL | Hospital |
| St Vincents Blount | Oneonta, AL | Hospital |
| St. Vincent's East | Birmingham, AL | Hospital |
| Lakeland Community Hospital | Haleyville, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tanner Intensive Medical Services Inc | 8729978622 | 11 |
| Paragon Contracting Services Llc | 3971417825 | 264 |
| Hoover Medicine, Inc. | 9638244601 | 3 |
News Archive
Neurological disorders may impact one's mental health, a new study says as researchers found that there is a higher rate of suicide among individuals living with neurological disorders.
Cumberland Pharmaceuticals Inc. today announced the publication of new data supporting the safety and efficacy of Caldolor® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen significantly decreased pain and morphine use when compared with placebo.
Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that the first patient was dosed in a Phase 1 pharmacokinetic clinical trial using Enhanze™ Technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation of a Roche biologic.
Researchers at Weill Cornell Medical College and Rockefeller University have identified the first gene to be linked to a rare condition in which babies are born without a spleen, putting those children at risk of dying from infections they cannot defend themselves against. The gene, Nkx2.5, was shown to regulate genesis of the spleen during early development in mice.
Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors - a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease and its treatment, says a new report from the Institute of Medicine.
› Verified 5 days ago
| Entity Name | Emergency Physician Associates, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467478628 PECOS PAC ID: 7113823246 Enrollment ID: O20031210000240 |
News Archive
Neurological disorders may impact one's mental health, a new study says as researchers found that there is a higher rate of suicide among individuals living with neurological disorders.
Cumberland Pharmaceuticals Inc. today announced the publication of new data supporting the safety and efficacy of Caldolor® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen significantly decreased pain and morphine use when compared with placebo.
Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that the first patient was dosed in a Phase 1 pharmacokinetic clinical trial using Enhanze™ Technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation of a Roche biologic.
Researchers at Weill Cornell Medical College and Rockefeller University have identified the first gene to be linked to a rare condition in which babies are born without a spleen, putting those children at risk of dying from infections they cannot defend themselves against. The gene, Nkx2.5, was shown to regulate genesis of the spleen during early development in mice.
Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors - a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease and its treatment, says a new report from the Institute of Medicine.
› Verified 5 days ago
| Entity Name | Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295040376 PECOS PAC ID: 2062408487 Enrollment ID: O20040421001819 |
News Archive
Neurological disorders may impact one's mental health, a new study says as researchers found that there is a higher rate of suicide among individuals living with neurological disorders.
Cumberland Pharmaceuticals Inc. today announced the publication of new data supporting the safety and efficacy of Caldolor® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen significantly decreased pain and morphine use when compared with placebo.
Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that the first patient was dosed in a Phase 1 pharmacokinetic clinical trial using Enhanze™ Technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation of a Roche biologic.
Researchers at Weill Cornell Medical College and Rockefeller University have identified the first gene to be linked to a rare condition in which babies are born without a spleen, putting those children at risk of dying from infections they cannot defend themselves against. The gene, Nkx2.5, was shown to regulate genesis of the spleen during early development in mice.
Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors - a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease and its treatment, says a new report from the Institute of Medicine.
› Verified 5 days ago
| Entity Name | Correct Care, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215987441 PECOS PAC ID: 8628980992 Enrollment ID: O20040615000906 |
News Archive
Neurological disorders may impact one's mental health, a new study says as researchers found that there is a higher rate of suicide among individuals living with neurological disorders.
Cumberland Pharmaceuticals Inc. today announced the publication of new data supporting the safety and efficacy of Caldolor® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen significantly decreased pain and morphine use when compared with placebo.
Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that the first patient was dosed in a Phase 1 pharmacokinetic clinical trial using Enhanze™ Technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation of a Roche biologic.
Researchers at Weill Cornell Medical College and Rockefeller University have identified the first gene to be linked to a rare condition in which babies are born without a spleen, putting those children at risk of dying from infections they cannot defend themselves against. The gene, Nkx2.5, was shown to regulate genesis of the spleen during early development in mice.
Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors - a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease and its treatment, says a new report from the Institute of Medicine.
› Verified 5 days ago
| Entity Name | Clay County Healthcare Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477551554 PECOS PAC ID: 5193700797 Enrollment ID: O20040618001157 |
News Archive
Neurological disorders may impact one's mental health, a new study says as researchers found that there is a higher rate of suicide among individuals living with neurological disorders.
Cumberland Pharmaceuticals Inc. today announced the publication of new data supporting the safety and efficacy of Caldolor® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen significantly decreased pain and morphine use when compared with placebo.
Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that the first patient was dosed in a Phase 1 pharmacokinetic clinical trial using Enhanze™ Technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation of a Roche biologic.
Researchers at Weill Cornell Medical College and Rockefeller University have identified the first gene to be linked to a rare condition in which babies are born without a spleen, putting those children at risk of dying from infections they cannot defend themselves against. The gene, Nkx2.5, was shown to regulate genesis of the spleen during early development in mice.
Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors - a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease and its treatment, says a new report from the Institute of Medicine.
› Verified 5 days ago
| Entity Name | The Sylacauga Health Care Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124235320 PECOS PAC ID: 5294710398 Enrollment ID: O20040727001079 |
News Archive
Neurological disorders may impact one's mental health, a new study says as researchers found that there is a higher rate of suicide among individuals living with neurological disorders.
Cumberland Pharmaceuticals Inc. today announced the publication of new data supporting the safety and efficacy of Caldolor® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen significantly decreased pain and morphine use when compared with placebo.
Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that the first patient was dosed in a Phase 1 pharmacokinetic clinical trial using Enhanze™ Technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation of a Roche biologic.
Researchers at Weill Cornell Medical College and Rockefeller University have identified the first gene to be linked to a rare condition in which babies are born without a spleen, putting those children at risk of dying from infections they cannot defend themselves against. The gene, Nkx2.5, was shown to regulate genesis of the spleen during early development in mice.
Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors - a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease and its treatment, says a new report from the Institute of Medicine.
› Verified 5 days ago
| Entity Name | Bessemer Emergency Physicians, Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932298536 PECOS PAC ID: 8820047913 Enrollment ID: O20050114000799 |
News Archive
Neurological disorders may impact one's mental health, a new study says as researchers found that there is a higher rate of suicide among individuals living with neurological disorders.
Cumberland Pharmaceuticals Inc. today announced the publication of new data supporting the safety and efficacy of Caldolor® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen significantly decreased pain and morphine use when compared with placebo.
Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that the first patient was dosed in a Phase 1 pharmacokinetic clinical trial using Enhanze™ Technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation of a Roche biologic.
Researchers at Weill Cornell Medical College and Rockefeller University have identified the first gene to be linked to a rare condition in which babies are born without a spleen, putting those children at risk of dying from infections they cannot defend themselves against. The gene, Nkx2.5, was shown to regulate genesis of the spleen during early development in mice.
Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors - a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease and its treatment, says a new report from the Institute of Medicine.
› Verified 5 days ago
| Entity Name | App Of Alabama Ed Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659646040 PECOS PAC ID: 3577725068 Enrollment ID: O20120430000174 |
News Archive
Neurological disorders may impact one's mental health, a new study says as researchers found that there is a higher rate of suicide among individuals living with neurological disorders.
Cumberland Pharmaceuticals Inc. today announced the publication of new data supporting the safety and efficacy of Caldolor® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen significantly decreased pain and morphine use when compared with placebo.
Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that the first patient was dosed in a Phase 1 pharmacokinetic clinical trial using Enhanze™ Technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation of a Roche biologic.
Researchers at Weill Cornell Medical College and Rockefeller University have identified the first gene to be linked to a rare condition in which babies are born without a spleen, putting those children at risk of dying from infections they cannot defend themselves against. The gene, Nkx2.5, was shown to regulate genesis of the spleen during early development in mice.
Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors - a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease and its treatment, says a new report from the Institute of Medicine.
› Verified 5 days ago
| Entity Name | Nes Tennessee, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437606605 PECOS PAC ID: 3678472040 Enrollment ID: O20161031002328 |
News Archive
Neurological disorders may impact one's mental health, a new study says as researchers found that there is a higher rate of suicide among individuals living with neurological disorders.
Cumberland Pharmaceuticals Inc. today announced the publication of new data supporting the safety and efficacy of Caldolor® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen significantly decreased pain and morphine use when compared with placebo.
Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that the first patient was dosed in a Phase 1 pharmacokinetic clinical trial using Enhanze™ Technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation of a Roche biologic.
Researchers at Weill Cornell Medical College and Rockefeller University have identified the first gene to be linked to a rare condition in which babies are born without a spleen, putting those children at risk of dying from infections they cannot defend themselves against. The gene, Nkx2.5, was shown to regulate genesis of the spleen during early development in mice.
Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors - a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease and its treatment, says a new report from the Institute of Medicine.
› Verified 5 days ago
| Entity Name | Sycamore Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1780372557 PECOS PAC ID: 9032573902 Enrollment ID: O20230911002503 |
News Archive
Neurological disorders may impact one's mental health, a new study says as researchers found that there is a higher rate of suicide among individuals living with neurological disorders.
Cumberland Pharmaceuticals Inc. today announced the publication of new data supporting the safety and efficacy of Caldolor® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen significantly decreased pain and morphine use when compared with placebo.
Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that the first patient was dosed in a Phase 1 pharmacokinetic clinical trial using Enhanze™ Technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation of a Roche biologic.
Researchers at Weill Cornell Medical College and Rockefeller University have identified the first gene to be linked to a rare condition in which babies are born without a spleen, putting those children at risk of dying from infections they cannot defend themselves against. The gene, Nkx2.5, was shown to regulate genesis of the spleen during early development in mice.
Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors - a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease and its treatment, says a new report from the Institute of Medicine.
› Verified 5 days ago
| Entity Name | Tanner Intensive Medical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568477313 PECOS PAC ID: 8729978622 Enrollment ID: O20240208000432 |
News Archive
Neurological disorders may impact one's mental health, a new study says as researchers found that there is a higher rate of suicide among individuals living with neurological disorders.
Cumberland Pharmaceuticals Inc. today announced the publication of new data supporting the safety and efficacy of Caldolor® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen significantly decreased pain and morphine use when compared with placebo.
Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that the first patient was dosed in a Phase 1 pharmacokinetic clinical trial using Enhanze™ Technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation of a Roche biologic.
Researchers at Weill Cornell Medical College and Rockefeller University have identified the first gene to be linked to a rare condition in which babies are born without a spleen, putting those children at risk of dying from infections they cannot defend themselves against. The gene, Nkx2.5, was shown to regulate genesis of the spleen during early development in mice.
Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors - a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease and its treatment, says a new report from the Institute of Medicine.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shelly Rhodes Weisenfeld, MD 774 Shades Mountain Plz, Hoover, AL 35226-1513 Ph: (205) 979-3381 | Dr Shelly Rhodes Weisenfeld, MD 774 Shades Mountain Plz, Hoover, AL 35226-1513 Ph: (205) 979-3381 |
News Archive
Neurological disorders may impact one's mental health, a new study says as researchers found that there is a higher rate of suicide among individuals living with neurological disorders.
Cumberland Pharmaceuticals Inc. today announced the publication of new data supporting the safety and efficacy of Caldolor® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen significantly decreased pain and morphine use when compared with placebo.
Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that the first patient was dosed in a Phase 1 pharmacokinetic clinical trial using Enhanze™ Technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation of a Roche biologic.
Researchers at Weill Cornell Medical College and Rockefeller University have identified the first gene to be linked to a rare condition in which babies are born without a spleen, putting those children at risk of dying from infections they cannot defend themselves against. The gene, Nkx2.5, was shown to regulate genesis of the spleen during early development in mice.
Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors - a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease and its treatment, says a new report from the Institute of Medicine.
› Verified 5 days ago
Dr. James H Marshall, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2949 John Hawkins Pkwy, Hoover, AL 35244 Phone: 205-987-0005 Fax: 205-987-0065 | |
Ashley Walker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2949 John Hawkins Pkwy, Hoover, AL 35244 Phone: 205-987-0005 | |
Maria E. Bennett, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5295 Preserve Pkwy, Suite 210, Hoover, AL 35244 Phone: 205-682-6077 Fax: 205-682-7646 | |
Dr. Dorothy E. Stephens Hughes, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5295 Preserve Pkwy, Suite 210, Hoover, AL 35244 Phone: 205-682-6077 Fax: 205-682-7646 | |
Dr. Michael T Solomon, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5295 Preserve Pkwy Ste 270, Hoover, AL 35244 Phone: 205-949-9289 Fax: 205-949-9290 | |
Jamie E. Bell, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 2547 John Hawkins Pkwy, Suite 103, Hoover, AL 35244 Phone: 205-988-8311 Fax: 205-988-3590 | |
Dr. Sherri Bennett Clark, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4745 Chace Cir, Suite 101, Hoover, AL 35244 Phone: 205-733-7110 Fax: 205-733-7859 |